Brainsway

Yahoo Finance • 10 days ago

BrainsWay Reports Expansion of Adolescent Depression Coverage Applicable to Deep TMS™

BrainsWay Optum Behavioral Health, a Health Services Company with Over 48 Million Covered Lives, Joins Growing List of Insurers Now Covering Deep TMS Depression Therapy for Adolescents Aged 15 and Older BURLINGTON, Mass. and JERUSALEM, D... Full story

Yahoo Finance • last month

BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company’s Growth Strategy and Deep TMS™ Treatment December 1, 2025

BURLINGTON, Mass. and JERUSALEM, Nov. 25, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced that it will... Full story

Yahoo Finance • last month

BrainsWay Launches First Clinical Trial of Deep TMS 360™ System for Alcohol Use Disorder

BURLINGTON, Mass. and JERUSALEM, Nov. 17, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced the launch of... Full story

Yahoo Finance • 2 months ago

BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21

BURLINGTON, Mass. and JERUSALEM, Israel, Nov. 13, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorde... Full story

Yahoo Finance • 2 months ago

Here are the major earnings before the open Tuesday

Major earnings expected before the bell on Tuesday include: * Nebius Group N.V. (NBIS [https://seekingalpha.com/symbol/NBIS]) * Sea Limited (SE [https://seekingalpha.com/symbol/SE]) * Workhorse Group (WKHS [https://seekingalpha.com/... Full story

Yahoo Finance • 2 months ago

BrainsWay Q3 2025 Earnings Preview

* BrainsWay (BWAY [https://seekingalpha.com/symbol/BWAY]) is scheduled to announce Q3 earnings results on Tuesday, November 11th, before market open. * The consensus EPS Estimate is $0.04 [https://seekingalpha.com/symbol/BWAY/earnings/... Full story

Yahoo Finance • 2 months ago

BrainsWay to Report Third Quarter 2025 Financial Results on November 11, 2025

BURLINGTON, Mass. and JERUSALEM, Oct. 28, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, toda... Full story

Yahoo Finance • 2 months ago

BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers

Recent agreements withtwo additional U.S. mental health providersbring total to four in 2025 Strategy seeks to drive long-term shareholder value BURLINGTON, Mass. and JERUSALEM, Oct. 27, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ... Full story

Yahoo Finance • 4 months ago

Brainsway stock maintains Buy rating at H.C. Wainwright after strategic investments

Investing.com - H.C. Wainwright has reiterated a Buy rating and $17.00 price target on Brainsway (NASDAQ:BWAY), the $288 million market cap medical device company that has delivered an impressive 61% return year-to-date. According to Inves... Full story

Yahoo Finance • 4 months ago

BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolief Ltd.

This investment marks BrainsWay’s entrance into the market for mental health therapies that can be administered outside of a clinic, including at home Neurolief’s breakthrough Proliv™Rx device is pending Premarket Approval from the U.S. F... Full story

Yahoo Finance • 4 months ago

BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health

BURLINGTON, Mass. and JERUSALEM, Aug. 20, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, toda... Full story

Yahoo Finance • 5 months ago

BrainsWay Reports Second Quarter 2025 Financial Results and Operational Highlights

Achieved record quarterly revenue of $12.6 million in Q2 2025, an increase of 26% compared to Q2 2024 Operating profit totaled $0.6 million and Adjusted EBITDA rose to $1.5 million, Raised full-year 2025 Revenue and EBITDA guidance Rema... Full story

Yahoo Finance • 5 months ago

S&P Futures Gain as Fed Rate-Cut Bets Firm

September S&P 500 E-Mini futures (ESU25 [https://www.barchart.com/futures/quotes/ESU25]) are trending up +0.24% this morning, extending yesterday’s gains as growing expectations for Federal Reserve interest rate cuts fueled risk-on sentime... Full story

Yahoo Finance • 5 months ago

Here are the major earnings before the open Wednesday

Major earnings expected before the bell on Wednesday include: * Tencent Holdings Limited (OTCPK:TCEHY [https://seekingalpha.com/symbol/TCEHY]) * Stratasys Ltd. (SSYS [https://seekingalpha.com/symbol/SSYS]) * Organigram Global (OGI [... Full story

Yahoo Finance • 2 years ago

Clinical TMS Society Publishes First Coverage Recommendations for the Treatment of Smoking Addiction

BURLINGTON, Mass. and JERUSALEM, Nov. 02, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, anno... Full story

Yahoo Finance • 2 years ago

BrainsWay to Report Third Quarter 2023 Financial Results on November 15, 2023

BURLINGTON, Mass. and JERUSALEM, Nov. 01, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, toda... Full story

Yahoo Finance • 2 years ago

BrainsWay Announces Presentation of Two Deep TMS™ Posters at Upcoming World Congress of Psychiatry

BURLINGTON, Mass. and JERUSALEM, Sept. 27, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, tod... Full story

Yahoo Finance • 3 years ago

BrainsWay Announces Significant Expansion in Western and Central U.S.

BURLINGTON, Mass. and JERUSALEM, June 21, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, toda... Full story

Yahoo Finance • 3 years ago

BrainsWay Reports First Quarter 2023 Financial Results and Operational Highlights

BrainsWay BURLINGTON, Mass. and JERUSALEM, May 17, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, today reported fir... Full story

Yahoo Finance • 3 years ago

BrainsWay Launches Investigator Initiated Study (IIS) Program

BURLINGTON, Mass. and JERUSALEM, May 15, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today... Full story